daunorubicin has been researched along with ascorbic acid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kolodziejczyk, P; Lown, JW; Reszka, K | 1 |
| Günzler, V; Hanauske, A; Hanauske-Abel, HM; Kaska, DD; Kivirikko, KI; Myllylä, R | 1 |
| Marián, M; Matkovics, B | 1 |
| Chibowski, D; Skomra, D | 2 |
| Gedig, E; Salyanov, VI; Spener, F | 1 |
| Celiński, K; Chibowska, I; Chibowski, D; Pokora, J | 2 |
| Au, WY; Kumana, CR; Kwong, YL; Lau, JS; Lee, HK; Lin, SY; Liu, H; Yeung, DY | 1 |
| Arshad, N; Nosheen, B; Nowsherwan, J; Perveen, F; Qureshi, R; Rafique, H; Sultan, A | 1 |
1 review(s) available for daunorubicin and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for daunorubicin and ascorbic acid
| Article | Year |
|---|---|
Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cytarabine; Daunorubicin; Disease-Free Survival; Dyspepsia; Female; Follow-Up Studies; Headache; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Tretinoin | 2011 |
11 other study(ies) available for daunorubicin and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Enzymatic oxidative activation of 5-iminodaunorubicin. Spectrophotometric and electron paramagnetic resonance studies.
Topics: Ascorbic Acid; Biotransformation; Daunorubicin; Electron Spin Resonance Spectroscopy; Horseradish Peroxidase; Hydrogen-Ion Concentration; Oxidation-Reduction; Spectrophotometry | 1989 |
Syncatalytic inactivation of prolyl 4-hydroxylase by anthracyclines.
Topics: Animals; Ascorbic Acid; Binding Sites; Catalysis; Chick Embryo; Daunorubicin; Doxorubicin; Humans; Kinetics; Oxidation-Reduction; Procollagen-Proline Dioxygenase | 1988 |
Potentiation of the biological activities of daunomycin and adriamycin by ascorbic acid and dimethylsulfoxide.
Topics: Animals; Ascorbic Acid; Daunorubicin; Dimethyl Sulfoxide; Doxorubicin; Drug Synergism; Female; Leukemia, Experimental; Mice; Saccharomyces cerevisiae; Staphylococcus aureus; Tetrahymena pyriformis | 1982 |
[Evaluation of daunorubicin nephrotoxicity and effect of tocopherol and ascorbic acid on lesions induced in rat kidneys. I. Histologic, histochemical and biochemical studies].
Topics: Animals; Ascorbic Acid; Daunorubicin; Hypoproteinemia; Kidney; Kidney Glomerulus; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar; Vitamin E | 1993 |
[Evaluation of daunorubicin nephrotoxicity and effect of tocopherol and ascorbic acid on lesions induced in rat kidneys. II. Ultrastructural studies of kidney glomeruli].
Topics: Animals; Ascorbic Acid; Basement Membrane; Daunorubicin; Kidney; Kidney Glomerulus; Male; Microscopy, Electron; Rats; Rats, Wistar; Vitamin E | 1993 |
Formation of polymeric chelate bridges between double-stranded DNA molecules fixed in spatial structure of liquid-crystalline dispersions.
Topics: Ascorbic Acid; Chelating Agents; Circular Dichroism; Copper; Crystallization; Daunorubicin; DNA; DNA, Superhelical; Models, Chemical; Models, Molecular; Nucleic Acid Conformation; Oxidation-Reduction; Polyethylene Glycols; Polymers | 1996 |
Ultrastructural studies of daunorubicin hepatotoxicity in rats including protective effects of tocopherol and ascorbic acid.
Topics: Animals; Ascorbic Acid; Cell Nucleus; Daunorubicin; Liver; Male; Microscopy, Electron; Organelles; Rats; Rats, Wistar; Vitamin E | 1996 |
Morphological and biochemical studies of daunorubicin hepatotoxicity including the protective effects of tocopherol and ascorbic acid.
Topics: Acid Phosphatase; Alanine Transaminase; Animals; Antibiotics, Antineoplastic; Ascorbic Acid; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Confidence Intervals; Daunorubicin; Liver Diseases; Male; Rats; Rats, Wistar; Vitamin E | 1995 |
Electrochemical, spectroscopic and theoretical monitoring of anthracyclines' interactions with DNA and ascorbic acid by adopting two routes: Cancer cell line studies.
Topics: Antibiotics, Antineoplastic; Antioxidants; Ascorbic Acid; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Epirubicin; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Neoplasms | 2018 |